Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

Medicine and Dentistry

• Nephrectomy 100%
• Patient 70%
• Overall Survival 40%
• Systemic Therapy 40%
• Targeted Therapy 30%
• Inpatient 20%
• Malignant Neoplasm 20%
• Clear Cell Renal Cell Carcinoma 20%
• Metastatic Carcinoma 20%
• Absence 20%
• Hazard Ratio 20%
• Karnofsky Performance Status 20%
• Cytokine Therapy 20%
• Cytokine 10%
• Diagnosis 10%
• Kidney Metastasis 10%
• Liver 10%
• Survival 10%
• Retrospective Study 10%
• Lung Metastasis 10%
• Predictor 10%
• Clinical Stage 10%
• Lactate Dehydrogenase 10%
• C Reactive Protein 10%